American doctors find out the new way for ease cancer’s patients last days &to=http://english.pravda.ru/main/2002/09/27/37328.html' target=_blank>fear, they are investigating whether the illegal "rave" drug &to=http://english.pravda.ru/society/2002/05/07/28308.html' target=_blank>Ecstasy can ease the anxiety of dying cancer patients in their final days. The Food and Drug Administration has approved a pilot study looking at whether the recreational hallucinogen can help terminally-ill patients lessen their fears, quell thoughts of suicide and make it easier for them to deal with loved ones.
Expected to start early next spring, the four-month study will test the drug's effects on 12 cancer patients from the Lahey Clinic Medical Centre in the Boston area.
The four-month study is expected to begin next spring and will test the drug’s effects on 12 cancer patients. The research is being sponsored by the Multidisciplinary Association for Psychedelic Studies. MAPS, on its website, said: "The longest day of winter has passed, and maybe so has the decades-long era of resistance to psychedelic research."
But it also suppresses appetite, thirst and the need to sleep, and in high doses can sharply increase body temperature, leading to kidney and heart failure, and death.